Abstract
Impaired cutaneous wound healing is a common complication in diabetes, ischemia and venous insufficiency of lower extremities, and in long-term treatment with corticosteroids or other immunosuppressive agents. In development of gene therapy for wound repair, expression of therapeutic transgenes should be precisely targeted and controlled. Here, we describe a recombinant adenovirus RAdFiRE-EGFP, in which a growth factor inducible element (FiRE) of the murine syndecan-1 gene controls the expression of enhanced green fluorescent protein (EGFP) reporter gene. Treatment of RAdFiRE-EGFP-transduced murine epidermal keratinocytes in culture with FiRE-activating growth factor markedly enhanced the expression of EGFP. In ex vivo organ culture of wounded murine skin transduced with RAdFiRE-EGFP, the EGFP expression was specifically detected in wound margin keratinocytes, but not in intact skin. Activity of EGFP was first detected 2 days after a single application of RAdFiRE-EGFP and persisted up to 10 days. Similarly, FiRE-driven EGFP expression was detected specifically in epidermal keratinocytes in the edge of incisional wounds in murine skin transduced with RAdFiRE-EGFP. In contrast, adenovirus-mediated lacZ expression driven by CMV promoter was detected scattered in epidermal, dermal and subcutaneous layers in ex vivo and in vivo wounds, as well as in intact skin. These data demonstrate the feasibility of FiRE as a tool for transcriptional targeting of adenovirus-mediated transgene expression to cutaneous wound edge keratinocytes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Singer AJ, Clark RAF . Cutaneous wound healing New Engl J Med 1999 341: 738–746
Brown GL et al. Enhancement of wound healing by topical treatment with epidermal growth factor New Engl J Med 1989 321: 76–79
Davidson JM, Broadley KN . Manipulation of the wound healing process with basic fibroblast growth factor Ann NY Acad Sci 1991 638: 306–315
Staiano-Coico L et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing J Exp Med 1993 178: 865–878
Danilienko DM et al. Growth factors in porcine full and partial thickness burn repair. Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor, and neu differentiation factor Am J Pathol 1995 147: 1261–1277
Yamasaki K et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer J Clin Invest 1998 101: 967–971
Lu B et al. Topical application of viral vectors for epidermal gene transfer J Invest Dermatol 1997 108: 803–808
Hengge UR, Walker PS, Vogel JC . Expression of naked DNA in human, pig, and mouse skin J Clin Invest 1996 97: 2911–2916
Yu WH et al. Topical gene delivery to murine skin J Invest Dermatol 1999 112: 370–375
Sawamura D et al. In vivo gene introduction into keratinocytes using jet injection Gene Therapy 1999 6: 1785–1787
Ghazizadeh S, Harrington R, Taichman L . In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy Gene Therapy 1999 6: 1267–1275
Siders WM, Halloran PJ, Fenton RG . Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells Cancer Res 1996 56: 5638–5646
Sandig V et al. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene Gene Therapy 1996 3: 1002–1009
Jeng MH et al. Reconstitution of estrogen-dependent transcriptional activation of an adenoviral target gene in select regions of the rat mammary gland Endocrinology 1998 139: 2916–2925
Kim S et al. Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo J Clin Invest 1997 100: 1006–1014
Jaakkola P, Vihinen T, Määttä A, Jalkanen M . Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells Mol Cell Biol 1997 17: 3210–3219
Jaakkola P, Määttä A, Jalkanen M . The activation and composition of FiRE (an FGF-inducible response element) differ in a cell-type and growth factor-specific manner Oncogene 1998 17: 1279–1286
Jaakkola P et al. Wound re-epithelialization activates a growth factor-responsive enhancer in migrating keratinocytes FASEB J 1998 12: 959–969
Stoscheck CM, Nanney LB, King LEJ . Quantitative determination of EGF-R during epidermal wound healing J Invest Dermatol 1992 99: 645–649
Galiano RD et al. Interaction between the insulin-like growth factor family and the integrin receptor family in the tissue repair processes. Evidence in a rabbit ear dermal ulcer model J Clin Invest 1996 98: 2462–2468
Goldfinger LE et al. The α3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin J Cell Sci 1999 112: 2615–2629
Liechty KW et al. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing J Invest Dermatol 1999 113: 375–383
Eming SA et al. Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft Hum Gene Ther 1998 9: 529–539
Eming SA et al. Particle-mediated gene transfer of PDGF isoforms promotes wound repair J Invest Dermatol 1999 112: 297–302
Rio MD et al. Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter Gene Therapy 1999 6: 1734–1741
Benn SI et al. Particle-mediated gene transfer with transforming growth factor-β1 cDNAs enhances wound repair in rat skin J Clin Invest 1996 98: 2894–2902
Fukumura D et al. Tumor induction of VEGF promoter activity in stromal cells Cell 1998 94: 715–725
Miller N, Whelan J . Progress in transcriptionally targeted regulatable vectors for genetic therapy Hum Gene Ther 1997 8: 803–815
Bennet N, Schultz G . Growth factors and wound healing: biochemical properties of growth factors and their receptors Am J Surg 1993 165: 728–737
Tsuboi R et al. Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes J Invest Dermatol 1993 101: 49–53
Beer HD, Longaker MT, Werner S . Reduced expression of PDGF and PDGF receptors during impaired wound healing J Invest Dermatol 1997 109: 132–138
Kolodka TM, Garlick JA, Taichman LB . Evidence for keratinocyte stem cells in vitro: long-term engraftment and persistence of transgene expression in retrovirus-transduced keratinocytes Proc Natl Acad Sci USA 1998 95: 4356–4361
Harvey BG et al. Cellular immune response of healthy individuals to intradermal administration of an E1-E3- adenovirus gene transfer vector Hum Gene Ther 1999 10: 2823–2837
Amalfitano A . Next-generation adenoviruses: new and improved Gene Therapy 1999 6: 1643–1645
Vihinen T et al. Functional characterization of mouse syndecan-1 promoter J Biol Chem 1996 271: 12532–12541
Graham FL, Prevec L . Methods for construction of adenovirus vectors Mol Biotechnol 1995 3: 207–220
Lu Y, Zhang Y, Steiner MS . Efficient identification of recombinant adenoviruses by direct plaque screening DNA Cell Biol 1998 17: 643–645
Wilkinson GW, Akrigg A . Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector Nucleic Acids Res 1992 20: 2233–2239
Ahonen M, Baker AH, Kähäri V-M . Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells Cancer Res 1998 58: 2310–2315
Acknowledgements
The authors are grateful to Mrs Hanna Haavisto, Mrs Taina Kalevo-Mattila and Mrs Anni Kieksi for expert technical help. Professor Seppo Ylä-Herttuala is acknowledged for fruitful discussions. This work was financially supported by the Academy of Finland, the Technical Research Center of Finland (TEKES), the Sigrid Jusélius Foundation, the Finnish Cancer Union, Turku University Central Hospital, Diabetes Research Foundation of Finland, Turku Graduate School of Biomedical Sciences, the Maud Kuistila Memorial Foundation (to PJ). PJ is Junior Research Fellow of the Academy of Finland.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jaakkola, P., Ahonen, M., Kähäri, VM. et al. Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element. Gene Ther 7, 1640–1647 (2000). https://doi.org/10.1038/sj.gt.3301293
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301293